About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Francisco | 209 Studies

Clinical Trials Prostate CancerSan Francisco

Prostate Cancer Clinical Trials in San Francisco

Find 209 clinical trials for prostate cancer near San Francisco, California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Francisco

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 209 trials

TerminatedGallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid CancerThis pilot clinical trial studies how well Gallium-68 prostate specific membrane antigen positron emission tomography (PET) work in diagnosing patients with thyroid cancer.NCT03463889·San Francisco, California RecruitingMagnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerThis is a single site, prospective pilot study to determine the feasibility and safety of the administration of HP 13C bicarbonate in 10 patients with prostate cancer to determine…NCT05851365·San Francisco, California TerminatedSandostatin for Patients With Androgen Independent Prostate CancerThis is an open label, single center Phase II trial of Sandostatin LAR in patients with hormone refractory prostate cancer.NCT00510224·San Francisco, California SuspendedA Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid TumorsThis is a first in human, single arm, open label, Phase 1a/1b study to determine the safety, feasibility, and efficacy of a single dose of NeoTCR-P1 T cells in participants with…NCT03970382·Duarte, California and 8 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of PainA study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.NCT00981578·Duarte, California and 4 others

Active not recruitingA Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsRADICAL PC1 is a prospective cohort study of men with a new diagnosis of prostate cancer.NCT03127631·Augusta, Georgia and 60 others

Terminated177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerThis Phase 1/2 study is intended to investigate the safety, tolerability, and radiation dosimetry of 177Lu-PSMA-R2 and further assess preliminary efficacy data in patients with…NCT03490838·Phoenix, Arizona and 10 others

TerminatedA Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1This is a non-randomized multi-center Phase 1b/2a dose escalation and dose expansion study testing DKN-01 as monotherapy or in combination with docetaxel in metastatic…NCT03837353·San Francisco, California and 4 others

RecruitingSacral Neuromodulation for Male Overactive Bladder (MOAB)To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.NCT06511141·Birmingham, Alabama and 22 others

CompletedComparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate CancerThis study will primarily compare the effectiveness of surgery and radiation for localized prostate cancer, the most common male cancer.NCT01326286·Los Angeles, California and 4 others

CompletedPlatform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel CombinationsThis study is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of immunotherapy combinations in…NCT03835533·Los Angeles, California and 5 others

RecruitingPilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate CancerThis pilot clinical trial studies how well magnetic resonance spectroscopic imaging (MRSI) with hyperpolarized carbon 13 (13C) pyruvate alone or in combination with 13C 15N2 Urea…NCT02526368·San Francisco, California

RecruitingA Study of NX-1607 in Adults With Advanced MalignanciesThis is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced…NCT05107674·Duarte, California and 16 others

CompletedPioneering Advances in Care and Education (PACE)This clinical trial evaluates the use of novel decision support educational materials and services using health coaches.NCT03397160·Palo Alto, California and 3 others

CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerThis study evaluates the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT imaging in patients with suspected recurrence of prostate cancer who have negative or…NCT03739684·Duarte, California and 13 others

Active not recruitingA Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in participants with…NCT04497844·Homewood, Alabama and 386 others

SuspendedMagnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate CancerThis is a prospective imaging study evaluating the utility of baseline metabolic MR imaging as a diagnostic and response monitoring tool in patients with advanced prostate cancer.NCT04346225·San Francisco, California

TerminatedA Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate CancerThere will be two parts to this clinical research study.NCT01717898·San Francisco, California

CompletedImmunotherapy in Patients With Metastatic Cancers and CDK12 MutationsThis study will attempt to determine the efficacy of checkpoint inhibitor immunotherapy with nivolumab and ipilimumab combination therapy followed by nivolumab monotherapy in…NCT03570619·San Diego, California and 7 others

CompletedS9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerRATIONALE: Hormones can stimulate the production of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00004124·Anchorage, Alaska and 233 others

Page 1 of 11Next

Other Conditions in San Francisco

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma